web analytics
27.7 C
Karachi
Monday, August 11, 2025
PSL 10
PSX
Gold Rates
Currency Exchange
HomeTagsRemdesivir

All Stories: remdesivir

US FDA approves COVID-19 drug for young children

The US drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences's...

India: People hire agents to stand in queue for Covid-19 drug Remdesivir

Owing to long queues, people are paying agents and locals ₹500 -₹1,500 to stand in for them in the drug queue.

Gang sells glucose solution as life-saving Covid drug, five arrested

It was involved in refilling vials with glucose solution and sell it as Remdesivir injection

WHO advises against remdesivir for all hospitalised COVID-19 patients

"Gilead’s remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are"

DRAP slashes price of COVID-19 drug

In a major relief to coronavirus patients, the Drug Regulatory Authority of Pakistan (DRAP) on Monday reduced the price of remdesivir, the first and only approved treatment for COVID-19 in the United States, by Rs1,629 to Rs9,244.

Pharma shares rise as United States approves remdesivir as COVID-19 drug

Shares of Gilead Sciences rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the US

WHO trial casts doubt on remdesivir and other drugs

Gilead's remdesivir was no better than a placebo at limiting severely ill patients' need for mechanical ventilation, says WHO

Britain rations remdesivir as COVID-19 hospitalisations rise

Britain has rationed its supplies of the antiviral drug remdesivir and is prioritising COVID-19 patients who need it most in the face of rising demand

Govt reduces price of COVID-19 drug remdesivir

The federal government announced to reduce prices of key lifesaving drugs, including remdesivir, being used for the treatment of critical COVID-19 patients

Remdesivir disappoints in COVID-19 study

A new study is raising fresh questions about the efficacy of Gilead Sciences' anti-viral medication remdesivir in COVID-19 patients

COVID-19: DRAP allows import, manufacturing of remdesivir

Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of remdesivir.

Govt ensuring availability of remdesivir for critical Covid-19 patients: Mirza

'FDA lately authorise the antiviral drug to treat coronavirus patients'

EU health regulator aims for approval of antiviral drug as COVID-19 treatment

European health regulator said it would look to fast-track the approval of this antiviral drug as a potential COVID-19 treatment in Europe

Taiwan approves anti-viral drug to treat COVID-19

Taiwan has been successful at preventing the coronavirus from spreading, thanks to early detection and prevention work and a first rate public health system

COVID-19: Study shows five-day course of remdesivir works as well as 10-day one

Gilead has pledged to donate 1.5 million doses of remdesivir - or enough to treat at least 140,000 patients - to fight the global pandemic

Anti-viral drug effective against coronavirus, study finds

The United States authorized the emergency use of remdesivir in hospitals on May 1, followed by Japan, while Europe is considering following suit.

Korean researchers find drug that is more effective in treating COVID-19 than remdesivir

A research team at the Institute Pasteur Korea have identified a drug that appears to be more effective in treating COVID-19 than Gilead’s remdesivir. The...

US firm has allowed Pakistani drugmakers to make COVID-19 drug: Zafar Mirza

Dr Mirza said that an American company Gilead has given a voluntary licence to five companies in South Asia and one of them is a Pakistani drug manufacturing company.

Gilead ties up with generic drugmakers for COVID-19 drug supply

The pacts allow the companies - Jubilant Life Sciences, Cipla , Hetero Labs, Mylan NV and Ferozsons Laboratories - to make and sell the drug in 127 countries

Japan approves drug as treatment for COVID-19

Japan reached the decision just three days after the U.S. drugmaker filed for fast-track approval for the treatment
Load more
-Advertisement-
 

Trending

BREAKING NEWS

MUST READ

ABOUT US

ARY NEWS brings you 24/7 Live Streaming, Headlines, Bulletins, Talk Shows, Infotainment, and much more. Watch minute-by-minute updates of current affairs and happenings from Pakistan and all around the world!

CORPORATE

ARY NETWORK

DOWNLOAD NOW!

© 2025 ARYNEWS.tv. All Rights Reserved.